| HOME | WALL STREET REPORT | THINKTANK | CLASSIC JACK | SUBSCRIPTION INFO | PORTFOLIO COMPANIES | MEDIA BUSINESS REPORT | ECONOMIC FORECASTS | RESEARCH |
"Supernatural" Gets Lucky
Published: September 26, 2007 at 02:35 PM GMT
Last Updated: October 17, 2007 at 02:35 PM GMT
Is that a rabbit's foot I see? Sound like it was lucky for actress Lauren Cohan who scored herself a recurring gig on Supernatural this season.
Supernatural's coming back darker and sexier than ever and here's what The CW has to say about the upcoming episodes:
Sam and Dean face all-out demonic war and as they work to stem the rising tide of demonic activity, they continue to travel the country, battling the supernatural wherever they go: changelings, cursed objects, vampires, witches, malevolent spirits, even a very unmerry Anti-Claus. Dean's clock is ticking, with Hell awaiting him in less than a year's time. Meanwhile, Sam still faces the fallout of the slain demon's plan to make him leader of the gathering demonic army. Wrestling many new questions about his destiny, Sam must uncover the dark secrets buried within his own past and within his family's history. And he must find a way to save his brother.
Episode three is titled Bad Day at Black Rock and it looks like both Sam and Dean are having a little trouble making it through the day unscathed!
Photos Marcel Williams/The CW 2007 The CW Network, LLC. All Rights Reserved
Archive
January 2012December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
See all Archived Material
Jack Myers ThinkTank 
Featured MediaBizBloggers
Social media has changed the way business is run. In virtually every industry the influence of Facebook, Twitter and community has altered many aspects of the business. Every industry, but one – the highly-regulated pharmaceutical business, remains largely on the outside looking in. This is, in no small part, due to a lack of guidance in the U.S. from the Food & Drug Administration (FDA). However, a breakthrough may have finally arrived in the form of language provided in the FDA's December 2011 Guidance for Industry procedural.
Read More
